The publications on this site are part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726

Informa
Skip to Page Content

Featured Deals

All
Industries

Acquisition Deals

Sartorius to acquire three Danaher life science businesses for $750mm
Deal Date: Oct-2019 / Publish Date: Oct-24-2019

Alexion buys Achillion for $930mm in cash
Deal Date: Oct-2019 / Publish Date: Oct-17-2019

Mallinckrodt divests BioVectra for $250mm as it focuses on specialty brands
Deal Date: Sep-2019 / Publish Date: Oct-23-2019

Alliance Deals

Novartis licenses global rights to Pliant's PLN147 for NASH
Deal Date: Oct-2019 / Publish Date: Oct-25-2019

Alexion gets exclusive option to Stealth's elamipretide
Deal Date: Oct-2019 / Publish Date: Oct-25-2019

Ipsen licenses exclusive global rights to Blueprint's FOP candidate BLU782
Deal Date: Oct-2019 / Publish Date: Oct-17-2019

Financing Deals

ProQR nets $54mm via FOPO
Deal Date: Oct-2019 / Publish Date: Oct-18-2019

Innate Pharma nets $73.5mm in initial public offering
Deal Date: Oct-2019 / Publish Date: Oct-25-2019

Principia nets $197.4mm through public offering
Deal Date: Oct-2019 / Publish Date: Oct-17-2019


Acquisition Deals

Klox acquires full ownership of FB Dermatology JV
Deal Date: Oct-2019 / Publish Date: Oct-17-2019

Alliance Deals

Teijin gains Japanese rights to NeuroSigma's Monarch eTNS device for ADHD
Deal Date: Oct-2019 / Publish Date: Oct-22-2019

Bryn licenses exclusive global rights to Aptar's bidose nasal delivery device
Deal Date: Oct-2019 / Publish Date: Oct-25-2019

LeMaitre buys Admedus' CardioCel and VascuCel patches
Deal Date: Oct-2019 / Publish Date: Oct-16-2019

Financing Deals

Clarify Medical raises $18mm in Series A round
Deal Date: Oct-2019 / Publish Date: Oct-25-2019


In Vitro Diagnostics

Email Alert |   RSS Feed

Financing Deals

Public offering nets $188mm for Natera
Deal Date: Oct-2019 / Publish Date: Oct-22-2019


Acquisition Deals

Zealand Pharma acquires fellow GI drug developer Encycle Therapeutics
Deal Date: Oct-2019 / Publish Date: Oct-23-2019

Alliance Deals

Bausch & Lomb gets US and Canadian rights to Clearside's Xipere
Deal Date: Oct-2019 / Publish Date: Oct-25-2019

Eyevance gains global license to Novartis' ophthalmic suspensions
Deal Date: Oct-2019 / Publish Date: Oct-24-2019

RedHill gets US rights to Cosmo's Aemcolo GI drug
Deal Date: Oct-2019 / Publish Date: Oct-18-2019

GSK divests two travel vaccines to Bavarian Nordic
Deal Date: Oct-2019 / Publish Date: Oct-21-2019

Takeda divests non-core assets to Acino in deal worth over $200mm
Deal Date: Oct-2019 / Publish Date: Oct-16-2019

Financing Deals

Healx gets $56mm via Series B
Deal Date: Oct-2019 / Publish Date: Oct-21-2019

Bryn Pharma raises $17.5mm through fourth financing round
Deal Date: Oct-2019 / Publish Date: Oct-25-2019

Rhythm Pharma nets $162mm via FOPO
Deal Date: Oct-2019 / Publish Date: Oct-17-2019

Biotechnology

Acquisition Deals

Sartorius to acquire three Danaher life science businesses for $750mm
Deal Date: Oct-2019 / Publish Date: Oct-24-2019

Alexion buys Achillion for $930mm in cash
Deal Date: Oct-2019 / Publish Date: Oct-17-2019

Mallinckrodt divests BioVectra for $250mm as it focuses on specialty brands
Deal Date: Sep-2019 / Publish Date: Oct-23-2019

Alliance Deals

Novartis licenses global rights to Pliant's PLN147 for NASH
Deal Date: Oct-2019 / Publish Date: Oct-25-2019

Alexion gets exclusive option to Stealth's elamipretide
Deal Date: Oct-2019 / Publish Date: Oct-25-2019

Ipsen licenses exclusive global rights to Blueprint's FOP candidate BLU782
Deal Date: Oct-2019 / Publish Date: Oct-17-2019

Financing Deals

ProQR nets $54mm via FOPO
Deal Date: Oct-2019 / Publish Date: Oct-18-2019

Innate Pharma nets $73.5mm in initial public offering
Deal Date: Oct-2019 / Publish Date: Oct-25-2019

Principia nets $197.4mm through public offering
Deal Date: Oct-2019 / Publish Date: Oct-17-2019

Medical
Devices

Acquisition Deals

Klox acquires full ownership of FB Dermatology JV
Deal Date: Oct-2019 / Publish Date: Oct-17-2019

Alliance Deals

Teijin gains Japanese rights to NeuroSigma's Monarch eTNS device for ADHD
Deal Date: Oct-2019 / Publish Date: Oct-22-2019

Bryn licenses exclusive global rights to Aptar's bidose nasal delivery device
Deal Date: Oct-2019 / Publish Date: Oct-25-2019

LeMaitre buys Admedus' CardioCel and VascuCel patches
Deal Date: Oct-2019 / Publish Date: Oct-16-2019

Financing Deals

Clarify Medical raises $18mm in Series A round
Deal Date: Oct-2019 / Publish Date: Oct-25-2019

In Vitro
Diagnostics

In Vitro Diagnostics

Email Alert |   RSS Feed

Financing Deals

Public offering nets $188mm for Natera
Deal Date: Oct-2019 / Publish Date: Oct-22-2019

Pharmaceuticals

Acquisition Deals

Zealand Pharma acquires fellow GI drug developer Encycle Therapeutics
Deal Date: Oct-2019 / Publish Date: Oct-23-2019

Alliance Deals

Bausch & Lomb gets US and Canadian rights to Clearside's Xipere
Deal Date: Oct-2019 / Publish Date: Oct-25-2019

Eyevance gains global license to Novartis' ophthalmic suspensions
Deal Date: Oct-2019 / Publish Date: Oct-24-2019

RedHill gets US rights to Cosmo's Aemcolo GI drug
Deal Date: Oct-2019 / Publish Date: Oct-18-2019

GSK divests two travel vaccines to Bavarian Nordic
Deal Date: Oct-2019 / Publish Date: Oct-21-2019

Takeda divests non-core assets to Acino in deal worth over $200mm
Deal Date: Oct-2019 / Publish Date: Oct-16-2019

Financing Deals

Healx gets $56mm via Series B
Deal Date: Oct-2019 / Publish Date: Oct-21-2019

Bryn Pharma raises $17.5mm through fourth financing round
Deal Date: Oct-2019 / Publish Date: Oct-25-2019

Rhythm Pharma nets $162mm via FOPO
Deal Date: Oct-2019 / Publish Date: Oct-17-2019

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel